Intended Use
The interferons represent proteins with antiviral activity secreted from cells in response to a variety of stimuli. In mammals class I interferon (IFN) genes form a superfamily consisting of three gene families, the alpha interferon (IFN-alpha), the beta interferon (IFN-beta) and the interferon omega (IFN-omega) genes. IFN-omega was found to compete with IFN alpha2 for binding to the cell membrane receptor type I. Potent antiviral activity was observed for IFN-omega in various assay systems. Furthermore, antiproliferative activity of IFN-omega was shown for human carcinoma cell lines. Immunomodulatory effects can as well be ascribed to IFN-omega. Its physiological role is currently not known. IFN-omega is unrelated to other human IFNs in terms of its antigenic characteristics which means there is no cross reactivity of antibodies to IFN-omega with other IFNs and vice versa. Therapeutically administered IFNw may cause measurable serum concentrations in the corresponding patients. Monitoring of these IFN-omega serum levels provides an important tool in therapy.
Contents of Kit
Microwell Plate
Biotin-Conjugate: 1 x120 μl
Streptavidin-HRP: 1 x150 μl
Standard: 2 x
Assay Buffer Concentrate 20x: 1 x5 ml
Wash Buffer Concentrate 20x: 1 x50 ml
Substrate Solution: 1 x15 ml
Stop Solution: 1 x15 ml
Blue-Dye: 1 x0.4 ml
Green-Dye: 1 x0.4 ml
Red-Dye: 1 x0.4 ml
Adhesive Films: 4 x
Detection Range
4.7 - 300 pg/mL
General Description
The interferons represent proteins with antiviral activity secreted from cells in response to a variety of stimuli. In mammals class I interferon (IFN) genes form a superfamily consisting of three gene families, the alpha interferon (IFN-alpha), the beta interferon (IFN-beta) and the interferon omega (IFN-omega) genes. IFN-omega was found to compete with IFN alpha2 for binding to the cell membrane receptor type I. Potent antiviral activity was observed for IFN-omega in various assay systems. Furthermore, antiproliferative activity of IFN-omega was shown for human carcinoma cell lines. Immunomodulatory effects can as well be ascribed to IFN-omega. Its physiological role is currently not known. IFN-omega is unrelated to other human IFNs in terms of its antigenic characteristics which means there is no cross reactivity of antibodies to IFN-omega with other IFNs and vice versa. Therapeutically administered IFNw may cause measurable serum concentrations in the corresponding patients. Monitoring of these IFN-omega serum levels provides an important tool in therapy.
Citations
Have you cited DEIABL348 in a publication?
Let us know and earn a reward for your research.
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Lockhart, BP; Cressey, KC; et al. Suppression of nitric oxide formation by tyrosine kinase inhibitors in murine N9 microglia. BRITISH JOURNAL OF PHARMACOLOGY 123:879-889(1998).
Hussain, M; Gill, DS; et al. Identification of interferon-alpha 7, -alpha 14, and -alpha 21 variants in the genome of a large human population. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH 16:853-859(1996).